Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease
- 3 August 2021
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 35 (9) , 2731-2733
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Vacuolization of hematopoietic precursors: an enigma with multiple etiologiesBlood, 2021
- Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune diseaseLeukemia, 2021
- Therapeutic options in VEXAS syndrome: insights from a retrospective seriesBlood, 2021
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory DiseaseNew England Journal of Medicine, 2020
- Autoimmune disease in CMML-the chicken or the egg?Best Practice & Research Clinical Haematology, 2020
- Integrating the “Immunome” in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial DesignJournal of Clinical Oncology, 2020
- Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaLeukemia Research, 2016
- Pathophysiology and management of inherited bone marrow failure syndromesBlood Reviews, 2010
- Hypocupremia and bone marrow failureHaematologica, 2008
- Vacuolization of the NeutrophilArchives of internal medicine (1960), 1966